Minodronic acid monohydrate

SKU: orb1298890

Description

Minodronic acid monohydrate is a potent and selective inhibitor of farnesyl diphosphate synthase (FDPS). This action inhibits osteoclast-mediated bone resorption, making it a valuable research tool for studying bone metabolism disorders, such as osteoporosis, in both cellular and animal models.

Research Area

Cell Biology, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery

Images & Validation

−

Key Properties

−

CAS Number	155648-60-5
MW	340.16
Purity	98.00% (May vary between batches)
Formula	C₉H₁₄N₂O₈P₂
SMILES	O.OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O
Target	Apoptosis,Transferase,P2X Receptor
Solubility	DMSO:3.41 mg/mL (10.02 mM);H2O:Insoluble

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Farnesyl diphosphate synthase, Minodronic acid, Minodronic acid monohydrate, Minodronic acid Monohydrate

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

23201029 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols